Stay updated with breaking news from Tim Dyer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Geneva, Switzerland, January 9, 2024 - Addex Therapeutics , a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, today announced that Dr...
The 11th volume in Harpswell author James Nelson's magnificent "Norsemen Saga," and author and essayist Janna Malamud Smith's fascinating study of Vinalhaven
Geneva, Switzerland, November 23, 2023 - Addex Therapeutics (SIX and Nasdaq: ADXN), a clinical-stage pharmaceutical company pioneering allosteric...
Geneva, Switzerland, November 23, 2023 - Addex Therapeutics , a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, today announced that that...
Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, November 8, 2023 - Addex Therapeutics (SIX and Nasdaq: ADXN), a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, today announced it had received written notification from The Nasdaq Stock Market LLC (Nasdaq) that it has regained compliance with the minimum bid price requirement of $1.00 per ADS under Nasdaq Listing Rule 5550(a)(2) and currently meets all other applicable cr